Description

Ambrolitin (ambroxol) syrup 15 mg/5 ml. 100 ml

Ingredients

Ambroxol Hydrochloride, sucrose, glycerol, citric acid, sodium benzoate, sodium citrate, sorbitol, raspberry flavor, purified water.

Dosage

Adults and children over 12 years: 10 ml 3 times a day. Children 6-12 years: 5 ml 2-3 times a day. Children 2-6 years: 2.5 ml 3 times a day.

Indications

Ambrolitin syrup is indicated for the treatment of respiratory diseases associated with viscid mucus, such as acute and chronic bronchitis, bronchial asthma, bronchiectasis, and pneumonia.

Contraindications

Do not use Ambrolitin syrup in patients with known hypersensitivity to ambroxol or any of the other ingredients. Consult a healthcare professional before use in pregnant or breastfeeding women.

Directions

Shake well before use. Use the provided measuring cup for accurate dosage. Can be taken with or without food. Do not exceed the recommended dosage.

Scientific Evidence

Ambroxol, the active ingredient in Ambrolitin syrup, is known for its mucolytic and expectorant properties. It works by thinning and loosening mucus in the airways, making it easier to cough up. Studies have shown that ambroxol can improve mucus clearance and reduce cough frequency in patients with respiratory conditions.

Additional Information

It is important to drink plenty of fluids while using Ambrolitin syrup to help loosen mucus. If symptoms persist or worsen, consult a healthcare provider. Store the syrup at room temperature away from direct sunlight.

Pharmacological Effects: Ambroxol acts by stimulating the production of surfactant in the lungs, which helps improve lung function and reduce respiratory symptoms. It also has antioxidant properties that can help protect lung tissue from damage.

Clinical Trials: Clinical trials have demonstrated the effectiveness of ambroxol in improving lung function and reducing exacerbations in patients with chronic respiratory conditions. A study published in the International Journal of Chronic Obstructive Pulmonary Disease showed that ambroxol treatment led to a significant improvement in lung function and quality of life in patients with chronic bronchitis.